60154 Federal Register / Vol. 69, No. 194 / Thursday, October 7, 2004 / Notices 

stop. For those driving, parking is $4.00. 

You must enter the parking lot at the 

‘‘Redland Center’’ entrance on Gaither 

Road, about one-eighth mile from 

Redland Boulevard.

FOR FURTHER INFORMATION CONTACT:

Judith Sangl (301) 427–1308.

SUPPLEMENTARY INFORMATION: The panel 

will concentrate on improving the 

overall framework for care planning in 

nursing homes. They will cover topics 

of patient-centered care, Resident 

Assessment Protocols (RAPs) format, 

clinical utility and ease of use (but not 

the specific content detail of the RAPs), 

informatics and decision support for 

care planning, and interdisciplinary 

planning.

Dated: October 5, 2004. 

Carolyn M. Clancy, 

Director.

[FR Doc. 04–22729 Filed 10–6–04; 8:45 am] 

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–04–04KK] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–498–1210 or send 

comments to Seleda Perryman, CDC 

Assistant Reports Clearance Officer, 

1600 Clifton Road, MS–E11, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov.

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Evaluation of ‘‘Steps to a 

HealthierUS’’ Program—New—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Description of 

Proposed Collection 

The Steps to a Healthier U.S. 

(HealthierUS) Program, known as 

STEPS, is an innovative program that 

advances the goals of helping 

Americans live longer, better, and 

healthier lives by preventing obesity, 

diabetes, and asthma. Forty 

communities across the country will or 

have received funding to develop and 

implement community action plans. 

These action plans will include 

multiple evidence-based public health 

strategies and interventions to increase 

healthy behavior change. 

The goal of this evaluation is to 

provide annual data on STEPS program 

outcomes in the STEPS communities 

collectively and a matched national 

sample, using a questionnaire that is 

tailored to the needs of the STEPS 

evaluation. The survey will be 

administered by computer assisted 

telephone interviews (CATI) annually in 

the STEPS sites and in a nationally 

representative (non-STEPS sites) sample 

of adults 18 years and older that is 

matched to key characteristics of the 

STEPS sites collectively (e.g., age, race/

ethnicity, income). The proposed survey 

will enable the CDC to determine if 

target outcomes are being achieved, and 

achieved more rapidly in Steps 

communities compared to the rest of the 

country. 

The survey will help answer key 

questions that cannot be adequately 

addressed by existing data 

infrastructures or by each sites’ local 

evaluation alone. In the absence of a 

comparison sample, it is not possible to 

know if progress in STEPS communities 

is simply a reflection of national secular 

trends or an impact of the interventions. 

By implementing a data collection 

system that is uniform across all STEPS 

sites and a national comparison sample, 

directly comparable data to answer 

specific research questions will be 

collected. Results from this data 

collection will help provide data 

necessary to develop innovative 

solutions that can be applied by states, 

communities, and CDC to improve the 

health behaviors of Americans. There 

are no costs to respondents except their 

time to respond.

ANNUALIZED BURDEN TABLE

Respondents Number of

respondents 

Number of

responses per 

respondent 

Average burden per

response

(in hrs.) 

Total burden 

hours 

Adults at STEPS sites ..................................................................................... 4000 1 25/60 1667 

Adults at Non-STEPS sites ............................................................................. 2000 1 25/60 833 

Total .......................................................................................................... 6000 ........................ ........................ 2500 

Federal Register / Vol. 69, No. 194 / Thursday, October 7, 2004 / Notices 60155

Dated: October 1, 2004. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–22549 Filed 10–6–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–04–0588] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–498–1210 or send 

comments to Seleda Perryman, CDC 

Assistant Reports Clearance Officer, 

1600 Clifton Road, MS-E11, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov.

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Evaluating the Impact of 

Lymphedema and a Lymphedema 

Management Intervention for Women 

with Lymphatic Filariasis: 

Understanding Issues Related to Quality 

of Life (OMB No. 0920–0588)—

Extension—National Center for 

Infectious Diseases (NCID), Centers for 

Disease Control and Prevention (CDC). 

Lymphatic filariasis, a mosquitotransmitted parasitic disease affecting 

over 120 million people, is the second 

leading cause of permanent disability 

worldwide. Globally, lymphatic 

filariasis causes debilitating genital 

disease in an estimated 25 million men 

and lymphedema or elephantiasis of the 

leg in 15 million people, mostly women 

in poverty stricken countries. The 

World Health Organization (WHO) 

recently identified community 

management of chronic lymphedema as 

one of the top twenty lymphatic 

filariasis research priorities. Recent 

advances in the management of chronic 

lymphedema include a prescribed 

hygiene and wound care intervention. 

This intervention has shown promising 

results in: (1) Preventing bacterial 

infections thus reducing acute attacks; 

(2) anecdotally improving overall 

quality of life; (3) alleviating pain; (4) 

and preventing further suffering. 

The data gathered from this study will 

assist CDC in the development, 

monitoring and evaluation of morbidity 

control programs, and the provision of 

technical assistance to collaborating 

countries in the Global Alliance to 

Eliminate Lymphatic Filariasis. The data 

collected by this study will allow CDC 

to determine directly from affected 

women such information as knowledge 

and attitudes related to disease and 

secondary infections; perceptions of 

women related to disease transmission; 

health seeking practices; and current 

self-care of women who are not under 

care as well as those who are. This 

formative data will be used to assist the 

Ministry of Health in each country to 

develop new lymphedema management 

programs and modify current public 

health educational campaigns to recruit 

affected populations into treatment. The 

data will also provide the basis for 

culturally-tailored public health 

education strategies that increase the 

community’s as well women’s 

knowledge of lymphatic filariasis, 

address barriers to health care seeking, 

debunk myths surrounding disease and 

morbidity, utilize traditional health care 

practitioners, train community health 

care workers in management 

techniques, inform programs of the 

psychological, physical, and emotional 

needs that women have, and other 

issues identified in research findings. 

In addition, the data findings will also 

be used on a global level (in 

collaboration with WHO, PAHO, the 

Liverpool School of Medicine, Emory 

University, and others) to develop 

process and outcome indicators for 

evaluating and monitoring treatment 

programs at the clinic-level, 

community-level and home-level. As 

new programs are initiated, critical 

evaluation measures are needed to 

measure the effectiveness of these 

programs to avoid spending money on 

ineffective strategies. Operationally this 

data will allow us to develop a public 

health strategy for women with disease 

and their communities that include the 

regimen of meticulous local hygiene to 

the affected areas. It will also allow us 

to develop critical evaluation indicators 

to ensure appropriate program 

monitoring so that information will be 

immediately available for assessment by 

both the affected countries and the 

donor agencies supporting program 

activities. Data will be widely 

disseminated in reports, presentations, 

and professional peer-reviewed 

publications to persons who work in 

prevention of this disease. There is no 

cost to respondents.

ANNUALIZED BURDEN TABLE

Questionnaires Number of

respondents 

Number of

responses per 

respondent 

Average burden per

response

(in hrs.) 

Total burden 

hours 

Qualitative Interviews ....................................................................................... 50 1 30/60 25 

Quantitative Survey ......................................................................................... 200 1 1 200 

Total .......................................................................................................... 250 ........................ ........................ 225